Assessing the Vaccination Status and Barriers to Influenza, Pneumococcal, and COVID-19 Vaccination Among Moroccan Patients With Chronic Inflammatory Rheumatic Disease.

Autor:	Ez-Zaoui S; Rheumatology, Ayachi Hospital, Ibn Sina Hospital Center, Rabat, MAR.; Rheumatology, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR., Rkain H; Rheumatology, Ayachi Hospital, Ibn Sina Hospital Center, Rabat, MAR.; Exercise Physiology and Autonomous Nervous System, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR., Kronbi F; Rheumatology, Ayachi Hospital, Ibn Sina Hospital Center, Rabat, MAR.; Rheumatology, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR., Benzine N; Rheumatology, Ayachi Hospital, Ibn Sina Hospital Center, Rabat, MAR.; Rheumatology, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR., Farih S; Rheumatology, Ayachi Hospital, Ibn Sina Hospital Center, Rabat, MAR.; Rheumatology, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR., Tahiri L; Rheumatology, Ayachi Hospital, Ibn Sina Hospital Center, Rabat, MAR.; Rheumatology, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR., Abouqal R; Biostatistics, Clinical and Epidemiological Research, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR., Hassouni K; Social Sciences, International School of Public Health, Mohammed VI University of Health Sciences, Casablanca, MAR., Hajjaj-Hassouni N; Rheumatology, Faculty of Medicine, Research Center of Health Sciences, International University of Rabat, Rabat, MAR., Allali F; Rheumatology, Ayachi Hospital, Ibn Sina Hospital Center, Rabat, MAR.; Rheumatology, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2024 Jun 04; Vol. 16 (6), pp. e61676. Date of Electronic Publication: 2024 Jun 04 (Print Publication: 2024).
DOI:	10.7759/cureus.61676
Abstrakt:	Objective: To evaluate the vaccination coverage of patients with chronic inflammatory rheumatic disease (CIRD) against influenza, pneumococcus, and COVID-19 and to determine, per the patients' point of view, the possible factors related to vaccination hesitation and/or refusal. Methods: A cross-sectional study carried out by the vaccination working group of the Moroccan Society of Rheumatology, including patients with CIRD in Morocco. Information about vaccination coverage and reasons for non-vaccination against influenza, pneumococcal infection, and COVID-19 was collected. Results: This survey included 230 patients (mean age of 46.9 +/-13.89 years; 68.7% females) affected by CIRD (rheumatoid arthritis 53%, spondyloarthritis 39.6%, psoriatic arthritis 7%). The study shows a significant lack of influenza and pneumococcal vaccination in CIRD patients, with vaccination coverage against influenza, pneumococcal infection, and COVID-19 at 2.2%, 0.4%, and 80.9%, respectively. The main reason for non-vaccination against influenza and pneumococcus was related to the absence of recommendations by their doctors (77%, 87%, p = 0.04). Additionally, the primary reason for non-vaccination against COVID-19 was the fear of the vaccine's side effects (51%, p = 0.0001), mainly a flare-up of CIRD (44%, p = 0.001). Conclusion: This survey shows a lack of influenza, pneumococcal, and COVID-19 vaccination in CIRD patients. The principal actions to improve vaccination should aim to educate patients and encourage rheumatologists to vaccinate their patients. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Ez-zaoui et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu